Pharmaceutical News

RSS

Antiscarring paste can halt fibrosis caused by radiation treatment

An antiscarring paste when applied to the skin of mice halts fibrosis caused by the radiation used in cancer therapy. That is according to a study led by researchers at Laura and Isaac Perlmutter Cancer Center to be published tomorrow in the January edition of the Journal of the Federation of American Societies for Experimental Biology, or FASEB.

5 Jan 2016

New guide provides valuable, unique overview of key properties of different drug targets

The new Concise Guide to PHARMACOLOGY 2015/2016 provides a valuable and unique overview of the key properties of more than 1,700 human drug targets, focusing on those exploited currently in the clinic or with future therapeutic potential.

5 Jan 2016

Sharp increase in drug shortages affects US emergency departments

A new study reveals that drug shortages affecting emergency care have skyrocketed in the United States in recent years. While the prevalence of such shortages fell from 2002 to 2007; the number of shortages sharply increased by 373% (from 26 to 123) from 2008 to 2014.

4 Jan 2016

Bayer to present new research findings on Xofigo (radium Ra 223 dichloride) injection at ASCO GU 2016

Bayer announced today that new research findings on Xofigo (radium Ra 223 dichloride) injection will be presented at the 2016 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (ASCO GU) taking place January 7 – 9 in San Francisco.

4 Jan 2016

CFDA issues new drug certificate and production license for Sinovac's EV71 vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that the China Food and Drug Administration issued the new drug certificate and production license for its Enterovirus 71 ("EV71") vaccine.

4 Jan 2016

Araim Pharmaceuticals forms new strategic collaboration with Vault Bioventures to market novel peptides

Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.

4 Jan 2016

World's largest database for cancer drug discovery revolutionised by 3D techniques

THE world's largest database for cancer drug discovery has been revolutionised by adding 3D structures of faulty proteins and maps of cancer's communication networks, according to Cancer Research UK-funded research published in Nucleic Acid Research today (Monday).

4 Jan 2016

Study unravels mechanisms by which saffron-based crocin prevents liver cancer

Liver cancer remains among the leading causes of cancer-related death worldwide. New study lead by UAE University Prof. Amr Amin unravels mechanisms by which saffron-based 'crocin' protects against liver cancer.

4 Jan 2016

Study: Taking high dose of vitamin D3 safe for people with multiple sclerosis

Taking a high dose of vitamin D3 is safe for people with multiple sclerosis and may help regulate the body's hyperactive immune response, according to a pilot study published by Johns Hopkins physicians in the Dec. 30 online issue of Neurology, the medical journal of the American Academy of Neurology.

31 Dec 2015

Treating multidrug-resistant tuberculosis with regimens may improve outcomes

Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.

30 Dec 2015

Delivering novel formulation of propranolol as liquid salt may reduce skin toxicity

Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity. A team of researchers from the University of California, Santa Barbara (UCSB) in Santa Barbara, CA has demonstrated a novel formulation of propranolol as a liquid salt which enables delivery through skin with reduced toxicity.

30 Dec 2015

Most patients with chronic pain continue to receive prescription opioids after nonfatal overdose

A study led by Boston Medical Center indicates that most patients with chronic pain who are hospitalized after a nonfatal opioid overdose continue to receive prescription opioids after the overdose and are at high risk for experiencing a repeated overdose.

30 Dec 2015

Opioid prescribing guideline has immediate, sustained impact on prescribing rates

Emergency medicine physicians at Temple University Hospital have found that an opioid prescribing guideline had an immediate and sustained impact on opioid prescribing rates for minor conditions and chronic noncancer pain in an acute care setting.

30 Dec 2015

Antibiotic prophylaxis may be recommended for dental patients

When the majority of patients go in for their dental visits there is not much of a risk for bacterial infection. But for a small number of people, the use of antibiotic prophylaxis may be recommended by your dentist.

30 Dec 2015

Go Healthy Natural releases new line of Antioxidant Boost liquid multivitamins

Go Healthy Natural, a leader in liquid daily dose multivitamins, has announced the launch of their new line of "Antioxidant Boost" liquid multivitamins. The two ounce daily dose liquid multivitamins will be sold in cases of 24 bottles with free shipping and be featured on www.GoHealthyNatural.com and www.Amazon.com.

30 Dec 2015

Mylan announces launch of Linezolid Tablets, 600 mg in U.S.

Mylan N.V. today announced the U.S. launch of Linezolid Tablets, 600 mg, which is the generic version of Pfizer's Zyvox Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria.

29 Dec 2015

Several therapies for hemophilia A, hemophilia B and hemophilia with inhibitors to be launched between 2015-2025

Decision Resources Group forecasts that several therapies will launch for hemophilia A, hemophilia B and hemophilia with inhibitors in the United States and Europe during our 2015-2025 study period.

29 Dec 2015

More than 90% of patients continue to receive prescription opioids after overdose

More than 90 percent of patients with chronic pain continue to receive prescription opioids after an overdose and are at high risk for experiencing a repeated overdose, according to an article published in Annals of Internal Medicine.

29 Dec 2015

FDA approves non-alcoholic Docetaxel Injection

Teikoku Pharma USA, Inc. announced today that the U.S. Food and Drug Administration has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel Injection") for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.

29 Dec 2015

PharmAthene to be compensated for loss of profits over SIGA's smallpox antiviral drug

PharmAthene, Inc. announced today that the Delaware Supreme Court affirmed the Delaware Court of Chancery's decision to award PharmAthene lump sum expectation damages for the value of PharmAthene's lost profits for SIGA's smallpox antiviral, Tecovirimat.

26 Dec 2015

Pharmaceutical News

Antiscarring paste can halt fibrosis caused by radiation treatment

New guide provides valuable, unique overview of key properties of different drug targets

Sharp increase in drug shortages affects US emergency departments

Bayer to present new research findings on Xofigo (radium Ra 223 dichloride) injection at ASCO GU 2016

CFDA issues new drug certificate and production license for Sinovac's EV71 vaccine

Araim Pharmaceuticals forms new strategic collaboration with Vault Bioventures to market novel peptides

World's largest database for cancer drug discovery revolutionised by 3D techniques

Study unravels mechanisms by which saffron-based crocin prevents liver cancer

Study: Taking high dose of vitamin D3 safe for people with multiple sclerosis

Treating multidrug-resistant tuberculosis with regimens may improve outcomes

Delivering novel formulation of propranolol as liquid salt may reduce skin toxicity

Most patients with chronic pain continue to receive prescription opioids after nonfatal overdose

Opioid prescribing guideline has immediate, sustained impact on prescribing rates

Antibiotic prophylaxis may be recommended for dental patients

Go Healthy Natural releases new line of Antioxidant Boost liquid multivitamins

Mylan announces launch of Linezolid Tablets, 600 mg in U.S.

Several therapies for hemophilia A, hemophilia B and hemophilia with inhibitors to be launched between 2015-2025

More than 90% of patients continue to receive prescription opioids after overdose

FDA approves non-alcoholic Docetaxel Injection

PharmAthene to be compensated for loss of profits over SIGA's smallpox antiviral drug

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News